Have £2,000 to invest in the FTSE 100? I’d buy these 2 bargain income stocks today

These two FTSE 100 (INDEXFTSE:UKX) dividend shares could deliver high returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The uncertain outlook for the UK economy could mean that interest rates remain at a low level for some time. In fact, there are rumours that the next move for interest rates could be downwards, with the Bank of England apparently becoming increasingly dovish as the prospects for the world economy remain challenging.

This could mean that dividend stocks offer increasingly appealing outlooks when compared to other mainstream assets. As such, now could be the right time to buy these two FTSE 100 income shares. They may deliver high income returns, as well as capital growth, over the long run.

GSK

The outlook for GSK (LSE: GSK) and the wider pharmaceuticals industry could improve significantly over the long run. Demand for healthcare-related products and services may rise due to an ageing global population, which could mean that the company’s decision to focus on its pharmaceutical operations leads to an improving rate of profit growth.

However, an improving financial outlook may take time to achieve. In the current year, GSK is forecast to post a fall in earnings of 3%, while growth of 2% in the next financial year may mean that investors struggle to become increasingly bullish about the stock from a growth perspective over the near term.

Of course, its defensive characteristics may boost its appeal in the short run. GSK’s lack of dependence on the wider economy for its growth could lead to increasing demand among investors who could become increasingly risk-averse. Since it offers a dividend yield of around 4.6%, its total returns may therefore be highly attractive.

As such, now could be a good time to buy the stock, with its income prospects, defensive appeal and long-term growth potential suggesting that it may outperform the FTSE 100.

Rio Tinto

Unlike GSK, FTSE 100 index peer Rio Tinto (LSE: RIO) lacks defensive appeal. Its financial performance is closely linked to the prospects for the world economy. Since there are concerns surrounding the outlook for China due in part to the global trade war, it would be unsurprising for the stock’s valuation to come under a degree of pressure in the near term.

However, Rio Tinto’s current valuation suggests that investors may have factored in many of the risks facing the business. It currently trades on a price-to-earnings (P/E) ratio of just 8, which indicates that it has a wide margin of safety. With the company having a relatively low level of gearing, it could prove to be more resilient than some of its sector peers should the performance of the world economy disappoint.

The stock’s dividend yield of 6.9% suggests that it could offer income investing potential over the long run. While there may be more stable income opportunities elsewhere in the FTSE 100, the iron ore miner may be able to produce a high overall return for patient investors.

Peter Stephens owns shares of GlaxoSmithKline and Rio Tinto. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

1 huge takeaway from the Martin Lewis investing presentation

Martin Lewis showed how returns from stocks have smashed the returns from cash savings over the last decade. But here’s…

Read more »

Middle aged businesswoman using laptop while working from home
Investing For Beginners

I think the best days for Lloyds’ share price are over. Here’s why

Jon Smith explains why Lloyds' share price could come under increasing pressure over the coming year, with factors including a…

Read more »

A graph made of neon tubes in a room
Investing Articles

£5,000 invested in the FTSE 100 at the start of 2025 is now worth…

Looking to invest in the FTSE 100? Royston Wild believes buying individual shares could be the best way to target…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Can the BAE share price do it again in 2026?

The BAE share price has been in good form in 2025. But Paul Summers says a high valuation might be…

Read more »

Investing Articles

Can Rolls-Royce, Babcock, and BAE Systems shares do it all over again in 2026?

Harvey Jones examines whether BAE Systems and other defence-focused FTSE 100 stocks can continue to shoot the lights out in…

Read more »

Investing Articles

7 UK dividend shares yielding over 7% that could thrive if rates fall in 2026

Mark Hartley weighs up the investment benefits of interest rate changes and how they could boost the potential of seven…

Read more »

Investing Articles

These 3 things could make a Stocks and Shares ISA a no-brainer in 2026

The government and the FCA are doing their bit to try to steer investors towards a Stocks and Shares ISA…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Revealed! The 10 best-performing FTSE 100 shares in 2025

It's been a year of golden gains for the FTSE 100 index, spearheaded by these 10 powerhouse stocks. But can…

Read more »